Burfiralimab (hzVSF-v13) is a monoclonal immunoglobulin (IgG4) directed against waveform proteins that has anti-HBV effects and can be used to study rheumatoid arthritis,
CAS Number:
[2460809-80-5]
Target:
HBV
* VAT and and shipping costs not included. Errors and price changes excepted